Sukoon Takaful PJSC (DFM:SUKOONTAKAFL)

Sage Therapeutics Cash Flow Statement

Financials in millions AED. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	22.83	18.99	-76.53	-30.68	6.44	29.37
Depreciation & Amortization	0.98	0.94	1.19	0.93	0.75	0.94
Other Amortization	-	-	-	0.22	0.19	0.12
Gain (Loss) on Sale of Assets	-	-	3.11	-0	-	-
Gain (Loss) on Sale of Investments	0.56	0.56	2.96	0.2	-3.9	-0.63
Change in Accounts Receivable	-	-	-	-	-9.89	1.32
Reinsurance Recoverable	-12.99	-34.75	0.06	-2.06	6.3	-12.01
Change in Insurance Reserves / Liabilities	58.09	34.07	24.64	39.11	1.23	-31.91
Change in Other Net Operating Assets	7.45	2.2	2.28	-0.2	13.7	-1.61
Other Operating Activities	-15.54	-16.19	-18.65	-13.17	-10.63	-13.98
Operating Cash Flow	43.57	-7.14	-49.43	-8.94	-3.7	-18.96
Capital Expenditures	-0.82	-0.08	-0.09	-0.53	-0.37	-0.32
Sale of Property, Plant & Equipment	-	-	0.15	0	-	-
Purchase / Sale of Intangible Assets	-0.16	-0.16	-0.13	-0.31	-0.18	-0.28
Investment in Securities	-64.64	-15.1	-106	1.22	-50.03	74.62
Other Investing Activities	19.7	17.91	15.04	13.8	10.47	13.07
Investing Cash Flow	-45.92	2.57	-7.56	14.18	-40.11	87.08
Total Debt Repaid	-0.66	-0.53	-0.53	-0.53	-0.52	-0.57
Net Debt Issued (Repaid)	-0.66	-0.53	-0.53	-0.53	-0.52	-0.57
Common Dividends Paid	-	-	-	-23.1	-15.4	-
Financing Cash Flow	-0.66	-0.53	-0.53	-23.63	-15.92	-0.57
Net Cash Flow	-3.01	-5.09	-57.51	-18.38	-59.73	67.56
Free Cash Flow	42.76	-7.22	-49.52	-9.47	-4.07	-19.28
Free Cash Flow Margin	36.09%	-7.73%	-55.49%	-6.60%	-4.04%	-17.19%
Free Cash Flow Per Share	0.28	-0.05	-0.32	-0.06	-0.03	-0.13
Levered Free Cash Flow	33.99	13.14	18.77	-14.5	0.3	-20.07
Unlevered Free Cash Flow	33.99	13.14	18.77	-14.5	0.3	-20.07
Change in Net Working Capital	-17.93	0.59	-65.63	-5.58	4.11	38.89

Source: S&P Global Market Intelligence. Insurance template. Financial Sources.